Welcome to our dedicated page for Walker & Dunlop SEC filings (Ticker: WD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Walker & Dunlop, Inc. (NYSE: WD) filings with the U.S. Securities and Exchange Commission, along with AI-powered tools that help interpret the information. Walker & Dunlop is a Maryland corporation whose common stock is listed on the New York Stock Exchange, and its SEC reports offer detail on its commercial real estate finance and advisory activities.
Among the filings available are Form 8-K current reports, which the company uses to disclose material events. Recent 8-Ks describe press releases reporting quarterly and year-to-date financial results, amendments to a Master Repurchase Agreement and related side letters with JPMorgan Chase Bank, N.A., changes to the board of directors, and performance-based equity awards for senior executives. These documents shed light on Walker & Dunlop’s capital structure, financing facilities, governance, and compensation practices.
Investors can also review filings that detail repurchase facilities used by Walker & Dunlop and its operating subsidiary, Walker & Dunlop, LLC. Amendments to these agreements adjust facility amounts, fees, and termination dates, illustrating how the company structures secured financing to support its commercial real estate activities.
On Stock Titan, AI-generated summaries highlight key points from lengthy filings, helping users quickly identify items such as new credit arrangements, changes in directorships, or disclosures about financial results. As additional forms such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and insider transaction reports on Form 4 are filed with the SEC, they can be incorporated into this page’s feed, with AI tools surfacing important terms, obligations, and governance details for easier review.
Walker & Dunlop EVP and Chief HR Officer Paula A. Pryor reported new equity awards and related tax withholding transactions. On
Each deferred and restricted stock unit represents the right to receive one share of common stock. The deferred stock units are fully vested and will be settled in shares under the company’s Management Deferred Stock Unit Purchase Plan. The restricted stock vests in three equal annual installments beginning on
Walker & Dunlop executive Daniel J. Groman, EVP, General Counsel, Secretary and Chief Compliance Officer, reported multiple equity awards and a tax-related share disposition. He acquired 6,466 deferred stock units, 3,233 restricted stock units, and 8,082 shares of common stock on February 13, 2026, all at a stated price of $0.00 per share as grant or award acquisitions.
The restricted stock vests in three equal annual installments beginning on February 15, 2027. Each deferred stock unit and each restricted stock unit represents the right to receive one share of Walker & Dunlop common stock, with settlement timing determined under the company’s Management Deferred Stock Unit Purchase Plan. To cover tax obligations, 1,471 shares of common stock were disposed of at $61.86 per share, leaving him with 22,305.266 common shares held directly after the transactions.
William M. Walker, Chairman & CEO of Walker & Dunlop, Inc., reported equity award settlements and share movements dated January 30, 2026. He acquired 7,829.986 shares of common stock at $0.00 per share upon the settlement of deferred stock units, restricted stock units, and related dividend equivalent rights. On the same date, he disposed of 3,251 common shares at $62.89 per share. Following these transactions, he directly owned 440,392.192 common shares, with additional indirect holdings of 540,147 shares through Walker Family Holdings LLC and 3,955 shares each as custodian for three sons.
Walker & Dunlop, Inc. entered into a Sixteenth Amendment to its Second Amended and Restated Warehousing Credit and Security Agreement with PNC Bank, National Association. The change, dated January 29, 2026, updates the warehousing facility to reduce the Applicable Daily Floating Term SOFR Rate, effectively lowering the interest benchmark on this financing line.
Walker & Dunlop, LLC remains the borrower under the warehousing facility, and Walker & Dunlop, Inc. continues to guarantee the borrower’s obligations. PNC and its affiliates also provide other financial services and engage in forward delivery and derivative arrangements with affiliates of the company in the ordinary course of business.
Walker & Dunlop Chairman and CEO files insider equity update
The Chairman and CEO of Walker & Dunlop, Inc. (WD), who also serves as a director, reported an equity-related transaction dated 12/05/2025. The filing shows an acquisition of 61.279 dividend equivalent rights, which are derivatives tied to the company’s common stock.
Each dividend equivalent right is the economic equivalent of one share of Walker & Dunlop common stock and accrued on restricted stock units already held by the executive. These rights vest proportionately with the related restricted stock units, at an exercise price of $0. Following this transaction, the executive directly beneficially owns 461.4314 derivative securities in the form of dividend equivalent rights linked to common shares.
Walker & Dunlop, Inc. officer EVP & Chief Operating Officer reported an equity-related transaction on 12/05/2025. The Form 4 shows the acquisition of 94.636 dividend equivalent rights, which the company states are economically equivalent to the same number of shares of its common stock.
The dividend equivalent rights were credited on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. After this transaction, the reporting person beneficially owned 1,292.685 dividend equivalent rights, held directly.
Walker & Dunlop, Inc. executive vice president and Chief HR Officer reported a routine equity-related transaction. On 12/05/2025, the officer acquired 19.75 dividend equivalent rights, each economically equivalent to one share of Walker & Dunlop common stock. These rights accrued on restricted stock units already held by the officer and will vest proportionately with those restricted stock units.
After this transaction, the officer beneficially owned 65.657 derivative securities tied to Walker & Dunlop common stock. The dividend equivalent rights were acquired at a stated price of $0, reflecting their nature as an adjustment linked to existing restricted stock unit awards rather than an open-market purchase.
Walker & Dunlop executive reports dividend equivalent rights
Walker & Dunlop, Inc. executive officer EVP, GC, Secretary & CCO filed a Form 4 reporting an equity-related transaction on 12/05/2025. The filing shows an acquisition (code "A") of 42.837 dividend equivalent rights, each economically equivalent to one share of Walker & Dunlop common stock, at a price of $0 per right.
The dividend equivalent rights accrued on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. Following this transaction, the executive beneficially owns 169.545 derivative securities of this type in direct ownership form.
Walker & Dunlop, Inc. executive vice president and chief financial officer reported an equity-related transaction involving derivative securities tied to the company’s common stock. On 12/05/2025, the officer acquired 24.451 dividend equivalent rights, each economically equivalent to one share of common stock, at a price of $0.
These dividend equivalent rights accrued on restricted stock units already held and will vest proportionately with those units over time. Following this transaction, the officer beneficially owned 99.938 derivative securities directly, reflecting ongoing alignment of compensation with the company’s equity performance rather than an open-market purchase or sale.
Walker & Dunlop (WD) filed its Q3 2025 10‑Q, reporting total revenues of $337.7 million, up from $292.3 million a year ago. Net income was $33.5 million versus $28.8 million, with diluted EPS of $0.98 compared to $0.85. For the nine months, revenues reached $894.3 million and net income was $70.2 million.
Growth was broad-based: loan origination and debt brokerage fees were $97.8 million, servicing fees were $85.2 million, property sales broker fees were $26.5 million, and fair value of expected net cash flows from servicing added $48.7 million. MSRs carried a net value of $806.0 million after $52.3 million of quarterly amortization. The at-risk Fannie Mae servicing portfolio CECL allowance was $24.8 million with a forecast-period loss rate of 2.1 basis points in Q3.
Total assets were $5.80 billion (up from $4.38 billion at year-end), driven by loans held for sale of $2.20 billion. Warehouse notes payable increased to $2.18 billion. Servicing UPB was $139.3 billion. The company maintained $6.05 billion of Agency warehouse capacity with $2.18 billion outstanding, and had a $450 million term loan (balance $447.8 million) plus $400 million of Senior Notes hedged via a fair value swap tied to SOFR. Allowance for risk‑sharing obligations was $34.1 million.